PURPOSE: To determine the prevalence and predictors of reversible myocardial perfusion defects, indicative of myocardial ischaemia, in patients with mild, stable anginal complaints [Canadian Cardiovascular Society classification (CCS) I-II/IV] and diabetes mellitus type 2 (T2DM). METHODS: A total of 329 patients with T2DM and stable, mild anginal symptoms (CCS I-II/IV) underwent myocardial perfusion scintigraphy. Perfusion images were assessed using a five-point (semi)-quantitative scoring system according to a 17-segment myocardial model. RESULTS: One-hundred and fifty-six (47%) patients showed reversible myocardial perfusion defects defined as a summed difference score of >or=3. Male gender [odds ratio (OR) 2.28, 95% CI 1.4-3.71, p=0.001], previous myocardial infarction (MI) without revascularisation (OR 3.04, 95% CI 1.28-7.24, p=0.01), and the use of two or more classes of anti-anginal medication (OR 2.36, 95% CI 1.48-3.76, p<0.001) were independent predictors for the presence of reversible defects. By contrast, lipid-lowering therapy reduced the possibility of reversible perfusion defects (OR 0.56, 95% CI 0.33-0.95, p=0.03). CONCLUSION: Approximately half of the patients with mild, stable angina pectoris and T2DM showed evidence of myocardial ischaemia. Male gender, previous MI and the use of anti-anginal medication were positive predictors and lipid-lowering therapy was a negative predictor for the results of the scintigraphic stress test.
PURPOSE: To determine the prevalence and predictors of reversible myocardial perfusion defects, indicative of myocardial ischaemia, in patients with mild, stable anginal complaints [Canadian Cardiovascular Society classification (CCS) I-II/IV] and diabetes mellitus type 2 (T2DM). METHODS: A total of 329 patients with T2DM and stable, mild anginal symptoms (CCS I-II/IV) underwent myocardial perfusion scintigraphy. Perfusion images were assessed using a five-point (semi)-quantitative scoring system according to a 17-segment myocardial model. RESULTS: One-hundred and fifty-six (47%) patients showed reversible myocardial perfusion defects defined as a summed difference score of >or=3. Male gender [odds ratio (OR) 2.28, 95% CI 1.4-3.71, p=0.001], previous myocardial infarction (MI) without revascularisation (OR 3.04, 95% CI 1.28-7.24, p=0.01), and the use of two or more classes of anti-anginal medication (OR 2.36, 95% CI 1.48-3.76, p<0.001) were independent predictors for the presence of reversible defects. By contrast, lipid-lowering therapy reduced the possibility of reversible perfusion defects (OR 0.56, 95% CI 0.33-0.95, p=0.03). CONCLUSION: Approximately half of the patients with mild, stable angina pectoris and T2DM showed evidence of myocardial ischaemia. Male gender, previous MI and the use of anti-anginal medication were positive predictors and lipid-lowering therapy was a negative predictor for the results of the scintigraphic stress test.
Authors: Daniel S Berman; Xingping Kang; Sean W Hayes; John D Friedman; Ishac Cohen; Aiden Abidov; Leslee J Shaw; Aman M Amanullah; Guido Germano; Rory Hachamovitch Journal: J Am Coll Cardiol Date: 2003-04-02 Impact factor: 24.094
Authors: Andrea De Lorenzo; Ronaldo S L Lima; Aristarco G Siqueira-Filho; Mauricio R Pantoja Journal: Am J Cardiol Date: 2002-10-15 Impact factor: 2.778
Authors: R Hachamovitch; D S Berman; H Kiat; I Cohen; H Lewin; A Amanullah; X Kang; J Friedman; G A Diamond Journal: Am J Cardiol Date: 1997-08-15 Impact factor: 2.778
Authors: H Miettinen; S Lehto; V Salomaa; M Mähönen; M Niemelä; S M Haffner; K Pyörälä; J Tuomilehto Journal: Diabetes Care Date: 1998-01 Impact factor: 19.112
Authors: Satyendra Giri; Leslee J Shaw; Dakshina R Murthy; Mark I Travin; D Douglas Miller; Rory Hachamovitch; Salvadore Borges-Neto; Daniel S Berman; David D Waters; Gary V Heller Journal: Circulation Date: 2002-01-01 Impact factor: 29.690
Authors: Jamieson M Bourque; Chetan A Patel; Mohamed M Ali; Margarita Perez; Denny D Watson; George A Beller Journal: Circ Cardiovasc Imaging Date: 2013-04-01 Impact factor: 7.792